[1] |
World Health Organization (WHO). World malaria report 2022[R]. Geneva: World Health Organization, 2023.
|
[2] |
Sima-Biyang YV, Ontoua SS, Longo-Pendy NM, et al. Epidemiology of malaria in Gabon: A systematic review and meta-analysis from 1980 to 2023[J]. J Infect Public Health. 2024, 17(7):102459.
|
[3] |
Boundenga L, Bignoumba M, Dibakou SE, et al. Decrease on malaria clinical cases from 2017 to 2019 in Franceville, Southeast Gabon, Central Africa[J]. J Public Health Afr. 2023, 14(3):1865.
|
[4] |
Li J, Docile HJ, Fisher D, et al. Current status of malaria control and elimination in Africa: Epidemiology, diagnosis, treatment, progress and challenges[J]. J Epidemiol Glob Health, 2024, 14(3):561-579.
doi: 10.1007/s44197-024-00228-2
pmid: 38656731
|
[5] |
Simião GM, Parreira KS, Klein SG, et al. Involvement of inflammatory cytokines, renal NaPi-IIa cotransporter, and TRAIL induced-apoptosis in experimental malaria-associated acute kidney injury[J]. Pathogens, 2024, 13(5):376.
|
[6] |
Batte A, Luyckx VA, Taylor TE, et al. Malaria guidelines fall short in diagnosing acute kidney injury[J]. Lancet Glob Health, 2024, 12(2):e194-e196.
|
[7] |
WHO Guidelines for malaria[R]. Geneva: World Health Organization, 2022.
|
[8] |
Lameire NH, Levin A, Kellum JA, et al. Harmonizing acute and chronic kidney disease definition and classification: Report of a kidney disease: Improving global outcomes (KDIGO) consensus conference[J]. Kidney Int, 2021, 100(3):516-526.
doi: 10.1016/j.kint.2021.06.028
pmid: 34252450
|
[9] |
Lendongo-Wombo JB, Oyegue-Liabagui SL, Biteghe-Bi-Essone JC, et al. Epidémiology of malaria from 2019 to 2021 in the southeastern city of Franceville, Gabon[J]. BMC Public Health, 2022, 22(1):2313.
|
[10] |
Bouyou-Akotet MK, Mawili-Mboumba DP, Kendjo E, et al. Evidence of decline of malaria in the general hospital of Libreville, Gabon from 2000 to 2008[J]. Malar J, 2009, 8:300.
|
[11] |
Woldearegai TG, Lalremruata A, Nguyen TT, et al. Characterization of Plasmodium infections among inhabitants of rural areas in Gabon[J]. Sci Rep, 2019, 9(1):9784.
doi: 10.1038/s41598-019-46194-9
pmid: 31278305
|
[12] |
Zoleko Manego R, Koehne E, Kreidenweiss A, et al. Description of Plasmodium falciparum infections in central Gabon demonstrating high parasite densities among symptomatic adolescents and adults[J]. Malar J, 2019, 18(1):371.
|
[13] |
Silke F, Earl L, Hsu J, et al. Cost-effectiveness of interventions for HIV/AIDS, malaria, syphilis, and tuberculosis in 128 countries: A meta-regression analysis[J]. Lancet Glob Health, 2024, 12(7):e1159-e1173.
|
[14] |
Feleke DG, Gebretsadik D, Gebreweld A. Analysis of the trend of malaria prevalence in Ataye, North Shoa, Ethiopia between 2013 and 2017[J]. Malar J, 2018, 17(1):323.
|
[15] |
Gul D, Rodríguez-Rodríguez D, Nate E, et al. Investigating differences in village-level heterogeneity of malaria infection and household risk factors in Papua New Guinea[J]. Sci Rep, 2021, ; 11(1):16540.
doi: 10.1038/s41598-021-95959-8
pmid: 34400687
|
[16] |
Liu J, Modrek S, Anyanti J, et al. How do risk preferences relate to malaria care-seeking behavior and the acceptability of a new health technology in Nigeria?[J]. BMC Health Serv Res, 2014, 14:374.
doi: 10.1186/1472-6963-14-374
pmid: 25192615
|
[17] |
Haeuser E, Serfes AL, Cork MA, et al. Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000-2018[J]. BMC Med, 2022, 20(1):488.
doi: 10.1186/s12916-022-02639-z
pmid: 36529768
|
[18] |
Nolasco-Pérez TJ, Cervantes-Candelas LA, Buendía-González FO, et al. Immunomodulatory effects of testosterone and letrozole during Plasmodium berghei ANKA infection[J]. Front Cell Infect Microbiol, 2023, 13:1146356.
|
[19] |
Sharma K, Mogensen KM, Robinson MK. Under-recognizing malnutrition in hospitalized obese populations: The real paradox[J]. Curr Nutr Rep, 2019, 8(4):317-322.
|
[20] |
Charani E, Cunnington AJ, Yousif AHA, et al. In transition: Current health challenges and priorities in Sudan[J]. BMJ Glob Health, 2019, 4(4):e001723.
|
[21] |
Mitsuboshi S, Imai S, Kizaki H, et al. Association between gastroprotective agents and acute kidney injury in patients receiving non-steroidal anti-inflammatory drugs: Analysis of a Japanese hospital-based database[J]. Pharmacotherapy, 2024, 44(11):851-860.
|
[22] |
Klomjit N, Ungprasert P. Acute kidney injury associated with non-steroidal anti-inflammatory drugs[J]. Eur J Intern Med, 2022, 101:21-28.
doi: 10.1016/j.ejim.2022.05.003
pmid: 35534373
|
[23] |
Goyal A, Daneshpajouhnejad P, Hashmi MF, Bashir K. Acute Kidney Injury[M].In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2025.
|
[24] |
Adu D, Okyere P, Boima V, et al. Community-acquired acute kidney injury in adults in Africa[J]. Clin Nephrol, 2016, 86(2016)(13):48-52.
doi: 10.5414/CNP86S121
|
[25] |
Cullis B, McCulloch M, Finkelstein FO. Development of PD in lower-income countries: Arational solution for the management of AKI and ESKD[J]. Kidney Int, 2024, 105(5):953-959.
doi: 10.1016/j.kint.2023.11.036
pmid: 38431214
|
[26] |
Miller NE, Rushlow D, Stacey SK. Diagnosis and management of sodium disorders: Hyponatremia and hypernatremia[J]. Am Fam Physician, 2023, 108(5):476-486.
pmid: 37983699
|
[27] |
Oppelaar JJ, Vuurboom MD, Wenstedt EFE, et al. Reconsidering the Edelman equation: Impact of plasma sodium concentration, edema and body weight[J]. Eur J Intern Med, 2022, 100:94-101.
doi: 10.1016/j.ejim.2022.03.027
pmid: 35393237
|